| scholarly article | Q13442814 |
| review article | Q7318358 |
| meta-analysis | Q815382 |
| P2093 | author name string | Theo Stijnen | |
| Ad J J C Bogers | |||
| Ozcan Birim | |||
| A Pieter Kappetein | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lung cancer | Q47912 |
| lymph node | Q170758 | ||
| meta-analysis | Q815382 | ||
| P1104 | number of pages | 8 | |
| P304 | page(s) | 375-382 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | The Annals of Thoracic Surgery | Q1939819 |
| P1476 | title | Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer | |
| P478 | volume | 79 |
| Q34546800 | (18)F-fluorodeoxyglucose positron emission tomography/computed tomography accuracy in the staging of non-small cell lung cancer: review and cost-effectiveness |
| Q46746418 | 18F-FDG PET for the lymph node staging of non-small cell lung cancer in a tuberculosis-endemic country: is dual time point imaging worth the effort? |
| Q36345601 | 18F-fluorodeoxyglucose positron emission tomography/computed tomography is useful in postoperative follow-up of asymptomatic non-small-cell lung cancer patients |
| Q37016566 | 18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review |
| Q96124417 | 2-[18F]FDG PET/CT radiomics in lung cancer: an overview of the technical aspect and its emerging role in management of the disease |
| Q37686084 | A pilot study of 4'-[methyl-11C]-thiothymidine PET/CT for detection of regional lymph node metastasis in non-small cell lung cancer |
| Q42211300 | An unusual presentation of a sarcoidosis that mimicked lymphatic metastatize non small cell lung carcinoma in positron emission tomography: a case report |
| Q92891743 | Analysis of low-scattering regions in optical coherence tomography: applications to neurography and lymphangiography |
| Q47171877 | Application of positron emission tomography-computed tomography in the diagnosis of pulmonary ground-glass nodules |
| Q64950841 | Clinical Characteristics of False-Positive Lymph Node on Chest CT or PET-CT Confirmed by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in Lung Cancer. |
| Q38945974 | Clinical PET-MR Imaging in Breast Cancer and Lung Cancer |
| Q37820757 | Computed tomography (CT) predicts accurately the pathologic tumour size in stage I non-small-cell lung cancer (NSCLC). |
| Q34493493 | Concurrent chemoradiotherapy with tomotherapy in locally advanced Non-Small Cell Lung Cancer: a phase I, docetaxel dose-escalation study, with hypofractionated radiation regimen |
| Q42905272 | Diagnosis of the presence of lymph node metastasis and decision of operative indication using fluorodeoxyglucose-positron emission tomography and computed tomography in patients with primary lung cancer |
| Q36797562 | ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. |
| Q42764860 | Evolution and science, progress and change |
| Q37060407 | Identification of false-negative and false-positive diagnoses of lymph node metastases in non-small cell lung cancer patients staged by integrated (18F-)fluorodeoxyglucose-positron emission tomography/computed tomography: A retrospective cohort stud |
| Q30399978 | Imaging the lymphatic system |
| Q36462717 | Increased x-ray attenuation in malignant vs. benign mediastinal nodes in an orthotopic model of lung cancer |
| Q35725371 | Lymphatic response to depilation-induced inflammation in mouse ear assessed with label-free optical lymphangiography. |
| Q26798247 | Magnetic resonance imaging for N staging in non-small cell lung cancer: A systematic review and meta-analysis |
| Q61804649 | Medically inoperable stage I non-small cell lung cancer: best practices and long-term outcomes |
| Q37643555 | Monitoring and management of lung cancer patients following curative-intent treatment: clinical utility of 2-deoxy-2-[fluorine-18]fluoro-d-glucose positron emission tomography/computed tomography |
| Q38210364 | Multimodality systematic approach to mediastinal lymph node staging in non-small cell lung cancer |
| Q34100976 | NOX4 promotes non-small cell lung cancer cell proliferation and metastasis through positive feedback regulation of PI3K/Akt signaling |
| Q35941636 | Negative predictive value of positron emission tomography and computed tomography for stage T1-2N0 non-small-cell lung cancer: a meta-analysis |
| Q33557567 | Non-invasive molecular imaging of prostate cancer lymph node metastasis |
| Q64962639 | Novel approach for predicting occult lymph node metastasis in peripheral clinical stage I lung adenocarcinoma. |
| Q60921254 | PET-CT has low specificity for mediastinal staging of non-small-cell lung cancer in an endemic area for tuberculosis: a diagnostic test study (LACOG 0114) |
| Q84379472 | PET-CT in the staging and treatment of non-small-cell lung cancer |
| Q33414911 | Phase II study of concurrent chemoradiotherapy with carboplatin and vinorelbine for locally advanced non-small-cell lung cancer |
| Q37301288 | Positron Emission Tomography (PET) radiotracers in oncology--utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC). |
| Q46981176 | Positron emission tomography imaging in nonsmall-cell lung cancer |
| Q47094024 | Potential clinical value of PET/CT in predicting occult nodal metastasis in T1-T2N0M0 lung cancer patients staged by PET/CT. |
| Q45154664 | Predictive factors of lymph node status in small peripheral non-small cell lung cancers: tumor histology is more reliable |
| Q36091529 | Predictive value of p16/Ki-67 immunocytochemistry for triage of women with abnormal Papanicolaou test in cervical cancer screening: a systematic review and meta-analysis |
| Q92566329 | Preoperative Risk Factors for Pathologic N2 Metastasis in Positron Emission Tomography-Computed Tomography-Diagnosed N0-1 Non-Small Cell Lung Cancer |
| Q38246442 | Prognostic value of volumetric parameters of (18)F-FDG PET in non-small-cell lung cancer: a meta-analysis |
| Q64275374 | Quantitative computed tomography texture analysis: can it improve diagnostic accuracy to differentiate malignant lymph nodes? |
| Q38931317 | Radiomic Analysis using Density Threshold for FDG-PET/CT-Based N-Staging in Lung Cancer Patients |
| Q51617508 | Risk Factors for Predicting Occult Lymph Node Metastasis in Patients with Clinical Stage I Non-small Cell Lung Cancer Staged by Integrated Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. |
| Q26863443 | Staging lymph node metastases from lung cancer in the mediastinum |
| Q36129173 | Staging non-small cell lung cancer |
| Q38834703 | Superior sulcus non-small cell lung carcinoma: A comparison of IMRT and 3D-RT dosimetry. |
| Q89821296 | The diagnostic accuracy of endobronchial ultrasound and spiral chest computed tomography scan in the prediction of infiltrating and non-infiltrating lymph nodes in patients undergoing endobronchial ultrasound |
| Q36660190 | The future in diagnosis and staging of lung cancer: surgical techniques |
| Q37131297 | The mediastinal staging accuracy of 18F-Fluorodeoxyglycose positron emission tomography/computed tomography in non-small cell lung cancer with variable time intervals to surgery |
| Q55221692 | The role of positron emission tomography in the diagnosis, staging and response assessment of non-small cell lung cancer. |
| Q41474160 | Update on nodal staging in non-small cell lung cancer with integrated positron emission tomography/computed tomography: a meta-analysis. |
| Q53526121 | Usefulness of the neutrophil-to-lymphocyte ratio in predicting lymph node metastasis in patients with non-small cell lung cancer. |
| Q42864238 | What is the role of FDG-PET in thoracic oncology in 2010? |
| Q83954005 | [Detection of lymph node involvement and surgical treatment of pulmonary neoplastic processes. Current state of diagnostic and therapeutic procedures] |
Search more.